87.49
price up icon0.36%   0.31
 
loading
Merck Co Inc stock is traded at $87.49, with a volume of 7.89M. It is up +0.36% in the last 24 hours and up +9.82% over the past month. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$87.18
Open:
$87.33
24h Volume:
7.89M
Relative Volume:
0.66
Market Cap:
$218.53B
Revenue:
$63.43B
Net Income/Loss:
$16.42B
P/E Ratio:
13.49
EPS:
6.4861
Net Cash Flow:
$14.72B
1W Performance:
+3.18%
1M Performance:
+9.82%
6M Performance:
+9.58%
1Y Performance:
-17.37%
1-Day Range:
Value
$87.11
$88.06
1-Week Range:
Value
$85.03
$88.79
52-Week Range:
Value
$73.31
$106.49

Merck Co Inc Stock (MRK) Company Profile

Name
Name
Merck Co Inc
Name
Phone
908-740-4000
Name
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Employee
75,000
Name
Twitter
@Merck
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
MRK's Discussions on Twitter

Compare MRK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.49 217.76B 63.43B 16.42B 14.72B 6.4861
Drug Manufacturers - General icon
LLY
Lilly Eli Co
825.45 736.03B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
190.40 463.72B 92.15B 25.12B 18.18B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.99 403.22B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
130.36 254.84B 53.40B 13.68B 16.89B 6.8864

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-13-25 Resumed Citigroup Neutral
Sep-17-25 Downgrade Berenberg Buy → Hold
May-14-25 Downgrade Citigroup Buy → Neutral
Apr-22-25 Initiated Cantor Fitzgerald Neutral
Feb-18-25 Downgrade Deutsche Bank Buy → Hold
Feb-10-25 Downgrade TD Cowen Buy → Hold
Jan-08-25 Downgrade Truist Buy → Hold
Dec-20-24 Downgrade BMO Capital Markets Outperform → Market Perform
Dec-10-24 Resumed BofA Securities Buy
Dec-04-24 Upgrade HSBC Securities Hold → Buy
Nov-15-24 Initiated Wolfe Research Peer Perform
Nov-11-24 Downgrade Daiwa Securities Buy → Neutral
Oct-17-24 Initiated Bernstein Mkt Perform
Mar-11-24 Downgrade Societe Generale Hold → Sell
Jan-04-24 Upgrade TD Cowen Market Perform → Outperform
Nov-09-23 Initiated Deutsche Bank Buy
Oct-27-23 Upgrade BMO Capital Markets Market Perform → Outperform
Oct-20-23 Upgrade UBS Neutral → Buy
Jul-14-23 Initiated HSBC Securities Hold
Apr-13-23 Upgrade Citigroup Neutral → Buy
Mar-28-23 Downgrade Societe Generale Buy → Hold
Mar-13-23 Downgrade Wells Fargo Overweight → Equal Weight
Mar-06-23 Initiated Jefferies Buy
Feb-22-23 Upgrade Wolfe Research Peer Perform → Outperform
Jan-04-23 Upgrade BofA Securities Neutral → Buy
Nov-18-22 Initiated Credit Suisse Outperform
Oct-10-22 Upgrade Guggenheim Neutral → Buy
Sep-14-22 Upgrade Berenberg Hold → Buy
Jul-06-22 Upgrade Daiwa Securities Neutral → Buy
Jun-06-22 Resumed SVB Leerink Outperform
Apr-06-22 Resumed Morgan Stanley Equal-Weight
Dec-17-21 Initiated Goldman Buy
Dec-16-21 Initiated Daiwa Securities Neutral
Dec-13-21 Downgrade UBS Buy → Neutral
Dec-09-21 Initiated Wells Fargo Overweight
Dec-07-21 Downgrade Guggenheim Buy → Neutral
Nov-29-21 Downgrade Citigroup Buy → Neutral
Nov-19-21 Initiated BMO Capital Markets Market Perform
Nov-01-21 Upgrade Argus Hold → Buy
Sep-07-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-27-21 Resumed Truist Buy
May-20-21 Downgrade Argus Buy → Hold
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Nov-10-20 Resumed Bernstein Outperform
Sep-29-20 Initiated Berenberg Hold
Aug-03-20 Upgrade Goldman Neutral → Buy
Jun-12-20 Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20 Initiated Barclays Overweight
Jan-07-20 Initiated RBC Capital Mkts Sector Perform
Oct-17-19 Resumed BofA/Merrill Neutral
Aug-16-19 Initiated SVB Leerink Outperform
Jul-03-19 Initiated Mizuho Buy
May-28-19 Initiated Goldman Neutral
May-13-19 Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18 Reiterated Citigroup Buy
Oct-09-18 Resumed Guggenheim Buy
Apr-23-18 Upgrade Goldman Neutral → Buy
Apr-17-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18 Upgrade Barclays Equal Weight → Overweight
Mar-12-18 Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18 Reiterated Leerink Partners Mkt Perform
Feb-07-18 Reiterated Morgan Stanley Equal-Weight
Jan-16-18 Upgrade SunTrust Hold → Buy
View All

Merck Co Inc Stock (MRK) Latest News

pulisher
10:31 AM

Kornitzer Capital Management Inc. KS Grows Stock Position in Merck & Co., Inc. $MRK - MarketBeat

10:31 AM
pulisher
09:52 AM

B & T Capital Management DBA Alpha Capital Management Acquires 4,072 Shares of Merck & Co., Inc. $MRK - MarketBeat

09:52 AM
pulisher
09:18 AM

SSA Swiss Advisors AG Purchases 7,180 Shares of Merck & Co., Inc. $MRK - MarketBeat

09:18 AM
pulisher
09:08 AM

Focus Partners Advisor Solutions LLC Has $6 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

09:08 AM
pulisher
08:46 AM

Merck & Co., Inc. $MRK Stake Boosted by Keeler Thomas Management LLC - MarketBeat

08:46 AM
pulisher
08:46 AM

State of New Jersey Common Pension Fund D Sells 4,014 Shares of Merck & Co., Inc. $MRK - MarketBeat

08:46 AM
pulisher
08:34 AM

Merck & Co., Inc. $MRK Shares Bought by Leelyn Smith LLC - MarketBeat

08:34 AM
pulisher
07:44 AM

Merck & Co., Inc. $MRK Shares Bought by PKO Investment Management Joint Stock Co - MarketBeat

07:44 AM
pulisher
06:13 AM

Cardinal Point Capital Management ULC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat

06:13 AM
pulisher
Oct 24, 2025

Merck Q3 Earnings Preview: Issues That Will Dominate The Agenda (NYSE:MRK) - Seeking Alpha

Oct 24, 2025
pulisher
Oct 24, 2025

Lee Danner & Bass Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

West Michigan Advisors LLC Sells 35,956 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Sumitomo Mitsui Trust Group Inc. Has $588.68 Million Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Sector Gamma AS Takes Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Moloney Securities Asset Management LLC Has $2.59 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Jackson Hole Capital Partners LLC Increases Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Merck & Co., Inc. $MRK Shares Bought by Generali Investments Towarzystwo Funduszy Inwestycyjnych - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

ARGA Investment Management LP Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

GLOBALT Investments LLC GA Trims Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Caitong International Asset Management Co. Ltd Invests $490,000 in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Merck & Co., Inc. $MRK Shares Bought by 180 Wealth Advisors LLC - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Bleakley Financial Group LLC Has $5.52 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Merck & Co., Inc. $MRK Shares Sold by Brookstone Capital Management - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Betamethasone Acetate Market Is Booming So Rapidly |Merck & Co., Inc., American Regent, Inc. - openPR.com

Oct 24, 2025
pulisher
Oct 23, 2025

Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally - The Motley Fool

Oct 23, 2025
pulisher
Oct 23, 2025

Stock of the WeekMerck & Co Inc (23.10.2025) - XTB.com

Oct 23, 2025
pulisher
Oct 23, 2025

FSM Wealth Advisors LLC Acquires 4,003 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Strata Wealth Advisors LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

First Citizens Bank & Trust Co. Sells 17,254 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Sells 14,614 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Clifford Swan Investment Counsel LLC Sells 2,872 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Merck Keytruda formulations undergo FDA priority review for bladder cancer - Seeking Alpha

Oct 23, 2025
pulisher
Oct 23, 2025

RNC Capital Management LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Freedom Investment Management Inc. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Forum Financial Management LP Sells 4,413 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Caliber Wealth Management LLC KS Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025 - FinancialContent

Oct 23, 2025
pulisher
Oct 23, 2025

Merck & Co., Inc. (MRK) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Cancer Drugs Market Is Booming So Rapidly | Pfizer Inc., Novartis AG, Merck & Co., Inc. - openPR.com

Oct 23, 2025
pulisher
Oct 22, 2025

Ethic Inc. Buys 8,003 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Birch Hill Investment Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Steel Grove Capital Advisors LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Family Capital Management Inc. Buys 5,122 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

D.A. Davidson & CO. Has $43.22 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Cullen Frost Bankers Inc. Sells 8,890 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Avidian Wealth Enterprises LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 22, 2025
pulisher
Oct 21, 2025

MRK Stock Quote Price and Forecast - CNN

Oct 21, 2025
pulisher
Oct 21, 2025

Analyst Says He’s Buying Merck (MRK) as ‘Market Turns Towards Quality’ - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Beech Hill Advisors Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Fiduciary Family Office LLC Has $1.03 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Whittier Trust Co. of Nevada Inc. Has $21.38 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 21, 2025

Merck Co Inc Stock (MRK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general NVO
$52.96
price down icon 0.51%
drug_manufacturers_general NVS
$130.36
price down icon 0.97%
$291.76
price down icon 0.39%
$120.94
price up icon 0.17%
drug_manufacturers_general PFE
$24.76
price up icon 0.36%
Cap:     |  Volume (24h):